Lawrence A. Shirley

Papers

1

Total Citations

21

H-Index

1

About

Lawrence A. Shirley is a surgical oncologist whose research focuses on the intersection of immunotherapy resistance and metastatic disease, particularly in gastrointestinal and hepatopancreaticobiliary malignancies. His most cited work, "The Adrenal Gland as a Sanctuary Site of Metastases After Pembrolizumab Treatment" (2018, 21 citations), provides critical insights into why certain organs, like the adrenal gland, may evade immune checkpoint blockade. This case series was among the first to identify the adrenal gland as a potential sanctuary site for metastases during PD-1 inhibitor therapy, highlighting intrapatient heterogeneous responses that challenge our understanding of treatment resistance. Shirley’s contributions extend to elucidating mechanisms of immune evasion and optimizing surgical strategies for complex cancers. His work has significant implications for personalizing immunotherapy combinations and guiding surgical interventions in patients with mixed treatment responses. By bridging clinical observation with translational research, Shirley continues to shape how oncologists approach metastatic disease in the era of immunotherapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
21
Total Citations
21
Avg Citations/Paper
🏆 Most Cited Paper
The Adrenal Gland as a Sanctuary Site of Metastases After Pembrolizumab Treatment: A Case Series
21 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 5

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago